EMA — authorised 7 December 2011
- Marketing authorisation holder: Takeda Pharma A/S
- Status: approved
🇪🇺 Edarbi in European Union
EMA authorised Edarbi on 7 December 2011
Marketing authorisation
Edarbi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Edarbi approved in European Union?
Yes. EMA authorised it on 7 December 2011.
Who is the marketing authorisation holder for Edarbi in European Union?
Takeda Pharma A/S holds the EU marketing authorisation.